Literature DB >> 17011280

Extrapleural pneumonectomy in children.

Raja M Flores1, Wendy Su, Dave Lal, Valerie W Rusch, Michael P La Quaglia.   

Abstract

BACKGROUND/
PURPOSE: Extrapleural pneumonectomy (EPP) is an en bloc resection of the pleura, lung, diaphragm, and pericardium. EPP in the pediatric population has not been reported in the literature. We report our experience of using EPP in children to treat a variety of malignancies that involve the pleural surface.
METHODS: We performed a retrospective review of all children treated through EPP at our institution. Data were obtained from patient charts and a pediatric database. All patients underwent en bloc resection of the pleura, lung, diaphragm, and pericardium and reconstruction.
RESULTS: Four patients underwent EPP from 2000 to 2004 for inflammatory myofibroblastic tumor, spindle cell sarcoma, metastatic neuroblastoma, and malignant mesothelioma. The patients' ages were from 6 to 11 years. The patient with metastatic neuroblastoma had recurrent disease in the left chest 1 year after EPP and died of sepsis; the patient with mesothelioma died of disease extension into the abdomen 1.5 years later. The other 2 patients are free of disease.
CONCLUSIONS: EPP can be performed with curative intent in selected pediatric patients with pleural-based malignancies. EPP should be included in the armamentarium of the pediatric thoracic surgeon and evaluated in larger studies.

Entities:  

Mesh:

Year:  2006        PMID: 17011280     DOI: 10.1016/j.jpedsurg.2006.05.063

Source DB:  PubMed          Journal:  J Pediatr Surg        ISSN: 0022-3468            Impact factor:   2.545


  2 in total

1.  Extrapleural Pneumonectomy for Sarcoma of the Lung in a Pediatric Patient.

Authors:  Michael Schweigert; Ana B Almeida; Jessica Pablik
Journal:  Thorac Cardiovasc Surg Rep       Date:  2022-03-03

2.  Extra-Pleural Pneumonectomy (EPP) in Children and Adults with Locally Advanced Sarcoma: A CanSaRCC Study.

Authors:  Caroline Rodrigues; Hagit Peretz Soroka; Agostino Pierro; Reto M Baertschiger; Marcelo Cypel; Laura Donahoe; Derek S Tsang; John Cho; Marc De Perrot; Thomas K Waddell; Abha A Gupta
Journal:  Curr Oncol       Date:  2022-06-15       Impact factor: 3.109

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.